How has the management of medullary thyroid carcinoma changed with the advent of 18F-FDG and non- 18F-FDG PET radiopharmaceuticals

Ka Kit Wong, Amanda M. Laird, Amir Moubayed, Sotirios Chondrogiannis, Maria Cristina Marzola, Laura Evangelista, Milton D. Gross, Domenico Rubello

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'How has the management of medullary thyroid carcinoma changed with the advent of <sup>18</sup>F-FDG and non- <sup>18</sup>F-FDG PET radiopharmaceuticals'. Together they form a unique fingerprint.

Medicine & Life Sciences